Dyslipidemia links obesity to early cerebral neurochemical alterations

Obesity

Volumn 21, Issue 10, 2013, Pages 2007-2013

  Haley, Andreana P ^a   Gonzales, Mitzi M ^a   Tarumi, Takashi ^a   Tanaka, Hirofumi ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; GLUCOSE; GLUTAMIC ACID; GLYCEROPHOSPHORYLCHOLINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INOSITOL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N ACETYLASPARTIC ACID; PHOSPHORYLCHOLINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BRAIN LEVEL; BRAIN METABOLISM; CEREBRAL NEUROCHEMISTRY; COGNITIVE DEFECT; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GRAY MATTER; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEAN ARTERIAL PRESSURE; NEUROCHEMISTRY; OBESITY; OCCIPITOPARIETAL GRAY MATTER; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; ASPARTIC ACID; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BRAIN; BRAIN DISEASES; CHOLESTEROL, HDL; CHOLINE; CREATINE; DYSLIPIDEMIAS; FEMALE; GLUTAMIC ACID; HUMANS; INOSITOL; LINEAR MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROCHEMISTRY; OBESITY; TRIGLYCERIDES;

EID: 84885375229     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20332     Document Type: Article

References (43)

1. Barness LA, Opitz JM, Gilbert-Barness E,. Obesity: Genetic, molecular, and environmental aspects. Am J Med Genet A 2007; 143A: 3016-3034.
2. WHO. Preventing Chronic Diseases: A Vital Investment: WHO Global Report. World Health Organization, Geneva, Switzerland; 2005.
3. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K,. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005; 330: 1360.
4. Gustafson D, Lissner L, Bengtsson C, Bjorkelund C, Skoog I,. A 24-year follow-up of body mass index and cerebral atrophy. Neurology 2004; 63: 1876-1881.
5. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005; 62: 1556-1560.
6. Ward MA, Carlsson CM, Trivedi MA, Sager MA, Johnson SC,. The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurol 2005; 5:5-23.
7. Volkow ND, Wang GJ, Telang F, et al. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity 2009; 17: 60-65.
8. Gazdzinski S, Kornak J, Weiner MW, Meyerhoff DJ, Nat R,. Body mass index and magnetic resonance markers of brain integrity in adults. Ann Neurol 2008; 63: 652-657.
9. Gazdzinski S, Millin R, Kaiser LG, et al. BMI and neuronal integrity in healthy, cognitively normal elderly: a proton magnetic resonance spectroscopy study. Obesity 2010; 18: 743-748.
10. Gonzales MM, Tarumi T, Eagan D, Tanaka H, Vaghasia M, Haley AP,. Indirect effects of elevated Body Mass Index on memory performance through altered cerebral metabolite concentrations. Psychosom Med 2012; 74: 691-698.
11. Brand A, Richter-Landsberg C, Leibfritz D,. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289-298.
12. Cloak CC, Chang L, Ernst T,. Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV. J Neuroimmunol 2004; 157: 147-152.
13. Kantarci K, Jack CR, Xu YC, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 2000; 55: 210-217.
14. Summers M, Swanton J, Fernando K, et al. Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease. J Neurol Neurosurg Psychiatry 2008; 79: 955-958.
15. Eagan DE, Gonzales MM, Tarumi T, Tanaka H, Stautberg S, Haley AP,. Elevated serum C-reactive protein relates to increased cerebral myo-inositol levels in middle-aged adults. Cardiovasc Psychiatry Neurol 2012;Epub 2012 Feb 22.
16. Bailey-Downs LC, Tucsek Z, Toth P, et al. Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation. J Gerontol A Biol Sci Med Sci 2012;Epub ahead of Print.
17. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79.
18. NIH. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, MD: National Institutes of Health; 1998.
19. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42-48.
20. Meyer JS, Rauch GM, Crawford K, et al. Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int J Geriatr Psychiatry 1999; 14: 1050-1061.
21. García Santos JM, Fuentes LJ, Vidal JB, et al. Posterior paralimbic and frontal metabolite impairments in asymptomatic hypertension with different treatment outcomes. Hypertens Res 2010; 33: 67-75.
22. Geissler A, Fründ R, Schölmerich J, Feuerbach S, Zietz B,. Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp Clin Endocrinol Diabetes 2003; 111: 421-427.
23. Haley AP, Gonzales MM, Tarumi T, Miles SC, Goudarzi K, Tanaka H,. Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome. Metab Brain Dis 2010; 25: 397-405.
24. Reiman EM, Chen KW, Alexander GE, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004; 101: 284-289.
25. Haley AP, Gunstad J, Cohen RA, Jerskey BA, Mulligan R, Sweet LH,. Neural correlates of visuospatial working memory in healthy young adults at risk for hypertension. Brain Imaging Behav 2008; 2: 192-199.
26. Provencher SW,. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679.
27. Danielsen ER, Ross, B,. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York, NY: Marcel Dekker, Inc.; 1999.
28. Baron RM, Kenny DA,. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986; 51: 1173-1182.
29. Preacher K, Hayes, A,. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Copmut 2004; 36: 717-731.
30. Preacher KJ, Hayes AF,. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008; 40: 879-891.
31. Greenberg RA, Sacks DB,. Screening for diabetes: is it warranted? Clin Chim Acta 2002; 315: 61-69.
32. Franssen R, Monajemi H, Stroes ESG, Kastelein JJP,. Obesity and dyslipidemia. Med Clin North Am 2011; 95: 893-902.
33. Farr SA, Yamada KA, Butterfield DA, et al. Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 2008; 149: 2628-2636.
34. de Frias CA, Bunce D, Wahlin A, et al. Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory functioning in older adults. J Gerontol B Psychol 2007; 62: P112-P118.
35. Perlmuter LC, Nathan DM, Goldfinger SH, Russo PA, Yates J, Larkin M,. Triglyceride levels affect cognitive function in noninsulin-dependent diabetics. J Diabet Complications 1988; 2: 210-213.
36. van den Kommer TN, Dik MG, Comijs HC, Jonker C, Deeg DJH,. The role of lipoproteins and inflammation in cognitive decline: Do they interact? Neurobiol Aging 2012; 33:e1-e12.
37. Toth PP,. The "good cholesterol"-high-density lipoprotein. Circulation 2005; 111: E89-E91.
38. Navab M, Ananthramaiah GM, Reddy ST, et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 2004; 45: 993-1007.
39. Scanu A, Molnarfi N, Brandt KJ, Gruaz L, Dayer JM, Burger D,. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins. J Leukoc Biol 2008; 83: 921-927.
40. Wadham C, Albanese N, Roberts J, et al. High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation 2004; 109: 2116-2122.
41. Atzmon G, Gabriely I, Greiner W, Davidson D, Schechter C, Barzilai N,. Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J Gerontol A Biol Sci Med Sci 2002; 57: M712-M715.
42. Vaisar T, Pennathur S, Green PS, et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 2007; 117: 746-756.
43. Movva R, Rader DJ,. Laboratory assessment of HDL heterogeneity and function. Clin Chem 2008; 54: 788-800.